本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Centessa Pharmaceuticals plc

24.76
+0.60502.51%
成交量:30.40萬
成交額:756.68萬
市值:33.19億
市盈率:-13.84
高:25.30
開:24.52
低:24.43
收:24.15
52周最高:25.30
52周最低:9.60
股本:1.34億
流通股本:8,495.06萬
量比:1.99
換手率:0.36%
股息:- -
股息率:- -
每股收益(TTM):-1.7885
每股收益(LYR):-2.0595
淨資產收益率:-72.92%
總資產收益率:-28.96%
市淨率:9.62
市盈率(LYR):-12.02

資料載入中...

2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities